Influence of the in vivo half-antibody exchange on the therapeutic efficacy of an IgG4 antibody-drug conjugate
A high number of therapeutic antibodies and their derivates e.g. antibody-drug conjugates (ADC) are under preclinical or clinical evaluation for the treatment of cancer. Most of those ADCs are based on the IgG1 or IgG4 subtype, depending on whether additional effector functions are desired or not. I...
Guardado en:
Autor principal: | |
---|---|
Otros Autores: | |
Formato: | Dissertation |
Lenguaje: | inglés |
Publicado: |
Philipps-Universität Marburg
2018
|
Materias: | |
Acceso en línea: | Texto Completo PDF |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|